• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Amorphous Solid Dispersions for Bioavailability Enhancement

    Dietary Supplement Quality Assurance Programs Critical to Natural Products Industry Success

    Manufacturing Dietary Supplements in Economic Uncertainty

    2023 Contract Manufacturing Survey

    New Possibilities for Small Batch Manufacturing
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Adragos Pharma Acquires Clinigen's Development Unit, Lamda Laboratories

    Vantage Nutrition Acquires ComboCap

    Secarna, SciNeuro Enter Research Agreement for CNS Diseases

    BioNTech Revenues Slide with Waning Demand for COVID-19 Vaccines

    Codiak BioSciences to File for Chapter 11
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    PharmaBlock Opens New R&D Facility in Pennsylvania

    Macfarlan Smith Annan Facility Marked for Closure  

    Northwest Bio, Advent BioServices Gain MHRA License for Commercial Manufacturing

    Willow, Suanfarma Complete Manufacturing Process for Cannabigerol

    Harm Reduction Therapeutics, Catalent Ink Naloxone Commercial Supply Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Adare Pharma Solutions Chooses Vantage to Lead Packaging Facility Upgrade

    This is Sofgen Pharmaceuticals

    Why Sofgen Pharmaceuticals?

    Stevanato, Recipharm Partner to Develop Pre-fillable Syringes for Soft Mist Inhaler

    Chewgels™ - An Explosive Experience with Innovative Technology
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Adragos Pharma Acquires Clinigen's Development Unit, Lamda Laboratories

    Secarna, SciNeuro Enter Research Agreement for CNS Diseases

    Pharming Gets FDA Nod for Joenja

    PharmaBlock Opens New R&D Facility in Pennsylvania

    Catalent Licenses Formulation Technology to Deliver High-Concentration Biologics
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Grand River Aseptic Manufacturing Receives Zero Observations from FDA Inspection

    Sofgen's Center for Pharmaceutical Excellence (CPhE)

    Dietary Supplement Quality Assurance Programs Critical to Natural Products Industry Success

    What Does the Future of Gene Therapy Hold?

    Automated Regulatory Electronic Publishing: How is It Changing the Industry?
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    CMC Pharmaceuticals

    Syngene International Ltd.

    INCOG BioPharma Services

    Societal CDMO

    Almac Group
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    CMC Pharmaceuticals

    Syngene International Ltd.

    INCOG BioPharma Services

    Societal CDMO

    Almac Group
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution

    Keeping up with counterfeitors in the pharmaceutical industry is no easy task, but patients’ lives depend on it.

    Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution
    Ben Locwin, Healthcare Science Advisors10.04.19
    Ever since there have been products, there have been counterfeit products distracting the consumer from the originator. There is a small philosophical difference between an originator product and a counterfeit—and that difference mostly centers around the idea of intellectual property (IP). IP attorneys spend long days justifying the differences, or lack thereof, between an originator and a copy. Trillions of dollars are made on knock-off products, and while some are of decent quality, others endeavor to convince consumers that they’re equivalent to the original product and (woefully) are not by a long shot. Oftentimes this discrepancy will manifest in a defective product and consumer frustration, but in the pharmaceutical market, counterfeits can lead to serious adverse events (SAEs) and even death.

    In pharmaceuticals, counterfeiting not only impacts IP of the originator molecule, but it undermines the safety of the public. Because unlike toys or gadgets, drug therapies go through a substantial demonstration of efficacy in clinical trials, so to intentionally develop inert, or hazardous, copies undermines the intent of the final product. This is where the ethical problems enter in the pharmaceutical counterfeiting market. Make no mistake: There is a tremendous incentive to counterfeit pharmaceutical products, as it is currently a scheme worth over $75 billion annually.1

    Techniques for anti-counterfeiting
    Branded labels and logos exist to signal to consumers that what they have is the original product. Of course, the counterfeitors then need to duplicate each of these product-specific idiosyncracies.

    There are many examples of anti-counterfeiting technology in pharmaceuticals that have been foiled: Manufacturer brand debossing on tablets can be copied; packages duplicated; tablet and capsule morphologies replicated; and containers cloned, or sourced from the same closure vendors. Those individuals most likely to be fooled by counterfeiting are first-time users of a drug therapy, because they have no mental baseline as a comparator. There are also a lot of first-time users of drug products. Think of the number of patients multiplied by the permutations of the number of marketed drug products.

    It was only a couple decades ago that holograms on stickers and logos were the 21st century approach to anti-counterfeiting. These are now easily duplicated by counterfeitors. Drug forms that come in novel delivery devices such as auto-injector pens, transdermal patches, etc., offer some inherent resistance to counterfeiting. But first-time users wouldn’t know what to expect.

    Now drugs that offer cutting-edge patient data tracking will provide some anti-counterfeiting comfort for the time being, until patients begin to refuse drug treatments that track compliance. Serialization allows for tracking and tracing to a certain degree across the supply chain and ensures greater chain of custody for the manufacturer, and as more pharmacies become a part of the serialization effort, the system gets more robust. But it does not demonstrate to patients that their prescription hasn’t been counterfeited.

    Special consideration for regulators
    This is a serious problem for the pharmaceutical industry, as it is for the technology sector, art, music, textiles, and virtually every other extant industry. Counterfeitors in the pharmaceutical sector, however, risk patients’ lives. There is a deep latent risk as well, and that comes in the form of post-marketing surveillance for safety reports. Knowing which reported adverse events (AEs) for a particular drug are from actual marketed drug or a counterfeit replacement is virtually impossible. Therefore knowing which post-marketing safety signals are false positives, which is already a difficult task, becomes more difficult when patients report adverse events and may have been taking a counterfeited prescription. It is therefore incumbent upon us as ambassadors for this industry to continue to seek methods to make counterfeiting more and more difficult. All patients who take a prescription and expect a certain beneficial effect, and at the same time a particular margin of safety, deserve the best products we can produce. CP

    References and Further Reading
    1. Moran, B. “Cracking Down on Counterfeit Drugs.” http://www.pbs.org/wgbh/nova/next/body/uncovering-counterfeit-medicines/
    2. Davison, M. (2011). Pharmaceutical anti-counterfeiting: Combating the real danger from fake drugs. Hoboken, NJ: John Wiley & Sons, Inc.

    Ben Locwin

    Dr. Ben Locwin, PhD, MBA, MS is president of Healthcare Science Advisors and an author of a wide variety of scientific articles for books and magazines, as well as an acclaimed speaker. He can be reached at ben.locwin@healthcarescienceadvisors.com.
    Related Searches
    • serialization
    • patients
    • events
    • Clinical Trials
    Suggested For You
    pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
    CEO Spotlight: Gaston Salinas, Botanical Solution Inc. CEO Spotlight: Gaston Salinas, Botanical Solution Inc.
    Boyds Opens US Office in PA Boyds Opens US Office in PA
    Gaston Salinas Botanical Solution Inc. Gaston Salinas Botanical Solution Inc.
    Trust, but Verify Trust, but Verify
    Raman Spectroscopy for Pharmaceutical Analysis & Quality Control Raman Spectroscopy for Pharmaceutical Analysis & Quality Control
    A Strong Partnership in Drug Development A Strong Partnership in Drug Development
    Putting Laboratory Suppliers to the Test in the COVID Era – and Beyond Putting Laboratory Suppliers to the Test in the COVID Era – and Beyond
    Choosing and Managing a CDMO Choosing and Managing a CDMO
    Global Outsourcing Trends Global Outsourcing Trends
    Three Tips for Navigating Post-Approval Pharmacovigilance Three Tips for Navigating Post-Approval Pharmacovigilance
    High Purity New England Expands Single-Use Portfolio High Purity New England Expands Single-Use Portfolio
    Lonza Appoints Philippe Deecke as CFO Lonza Appoints Philippe Deecke as CFO
    Bachem and Novo Nordisk Redesign SPPS for Green Chemistry Bachem and Novo Nordisk Redesign SPPS for Green Chemistry
    Pfizer to Acquire Trillium Therapeutics for $2.3B Pfizer to Acquire Trillium Therapeutics for $2.3B

    Related Breaking News

    • Breaking News | Clinical Trials
      pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray

      pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray

      According to the study, the novel prophylactic nasal spray prevented infection from SARS-CoV-2, the virus that causes COVID-19.
      09.22.21

    • Biologics, Proteins, Vaccines
      CEO Spotlight: Gaston Salinas, Botanical Solution Inc.

      CEO Spotlight: Gaston Salinas, Botanical Solution Inc.

      QS-21 has become the ‘Gold Standard’ for human vaccine adjuvants and BSI is positioned to become a reliable supplier to the pharmaceutical market.
      Tim Wright, Editor, Contract Pharma 09.14.21

    • Breaking News | Promotions & Moves
      Boyds Opens US Office in PA

      Boyds Opens US Office in PA

      Welcomes Katy Rudnick as VP and head of US regulatory affairs.
      09.13.21


    • Gaston Salinas Botanical Solution Inc.

      Gaston Salinas Botanical Solution Inc.

      QS-21 has become the ‘Gold Standard’ for human vaccine adjuvants and BSI is positioned to become a reliable supplier to the pharmaceutical market.
      Tim Wright, Editor 09.09.21

    • Trust, but Verify

      Trust, but Verify

      Or, R.I.P, CoA.
      Emil W. Ciurczak, DoraMaxx Consulting 09.09.21

    Loading, Please Wait..
    Trending
    • Merck KGaA Secures Exclusive Worldwide Rights To Bavencio
    • Codiak BioSciences To File For Chapter 11
    • BioNTech Revenues Slide With Waning Demand For COVID-19 Vaccines
    • How Industry 5.0 Might Benefit Pharmaceutical Manufacturing
    • Jubilant HollisterStier Appoints Chris Preti President
    Breaking News
    • Adragos Pharma Acquires Clinigen's Development Unit, Lamda Laboratories
    • Vantage Nutrition Acquires ComboCap
    • Secarna, SciNeuro Enter Research Agreement for CNS Diseases
    • BioNTech Revenues Slide with Waning Demand for COVID-19 Vaccines
    • Codiak BioSciences to File for Chapter 11
    View Breaking News >
    CURRENT ISSUE

    March 2023

    • Amorphous Solid Dispersions for Bioavailability Enhancement
    • Dietary Supplement Quality Assurance Programs Critical to Natural Products Industry Success
    • Manufacturing Dietary Supplements in Economic Uncertainty
    • 2023 Contract Manufacturing Survey
    • New Possibilities for Small Batch Manufacturing
    • Supply Chain Risk Management
    • 3 Ways Pharma Can Outsmart Talent Challenges in 2023
    • Nutraceutical Dosage Trends: Functional Gummies Offer Alternative to Tablets and Capsules
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Melodea Launches New Plastic-Free Packaging Solution
    GOED and NASC Announce Strategic Partnership
    NPA: ‘Major Victory’ in Colorado After Amendment to Eating Disorder Bill
    Coatings World

    Latest Breaking News From Coatings World

    HOFFMANN MINERAL to Focus on Comprehensive Sustainability Strategy
    HMG and Prodrive Renew Technical Partnership
    Eastern Coatings Show Sets Schedule for Technical Papers
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs FemDx Medsystems' FalloView Device
    FDA Clears NeuroRPM Parkinson's Disease Monitoring Tech
    Vaporox Earns FDA Nod for VHT-200 Wound Care Device
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Adragos Pharma Acquires Clinigen's Development Unit, Lamda Laboratories
    Vantage Nutrition Acquires ComboCap
    Secarna, SciNeuro Enter Research Agreement for CNS Diseases
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Thread Beauty Expands Cosmetics Line at Target
    The Body Shop Expands its Refill Program in Canada
    Clinique Introduces Digital Retail Concept—Clinique Lab
    Happi

    Latest Breaking News From Happi

    Arbonne Welcomes New Executives
    Total Sales for Naples Soap Company in 2022 Increase 2% Despite Inflation, Supply Chain Issues
    IBA Supports FDA in the MoCRA Rulemaking and Implementation Process
    Ink World

    Latest Breaking News From Ink World

    hubergroup Print Solutions Presents Sustainable Portfolio at PAMEX 2023
    Weekly Recap: Packaging Inks, Toyo Ink Top This Week’s Stories
    Eastern Coatings Show Announces Schedule for Technical Papers
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    eProductivity Software acquires Tharstern Group
    Imageworx details new facility, Avery Dennison tackles recycling and more
    TLMI announces 2022 Eugene Singer Award winners
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Period Care Brand August Launches in Target Stores
    Albany International Announced CEO Succession Plan
    Ahlström Partners to Make Sustainable Butter, Margarine Packaging
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Exactech Boosts AI Expertise with Licensing Deal, Team of Scientists
    Anchor Harvey Celebrates 100th Anniversary in 2023
    Arjun Ishwar Joins Miach Orthopaedics as Sales and Marketing VP
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    onsemi Honored with Supplier of the Year 2022 Award by Hyundai Motor Group 
    Weekly Recap: Dave Rahami, Zebra, Dracula Technologies Top This Week’s Stories
    Midsummer, UCLA Collaborate on Perovskite-CIGS Tandem Solar Cells

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login